Treatment type: Cell therapies
-
World-first stem cell therapy for acute stroke examined in new trial
A world‐first safety trial is underway examining amniotic stem cells as therapy for acute stroke. The study is a partnership between Hudson Institute of Medical Research, Monash Health and La Trobe University.… Read more
-
Natural mesh provides hope for pelvic organ prolapse
A safer and more effective treatment for women with pelvic organ prolapse (POP) may be on the horizon, thanks to a new technique that uses a woman’s own stem cells to boost the effectiveness of a degradable mesh. A study published in Biomacromolecules, led by Dr Shayanti Mukherjee, shows how a degradable mesh, made from… Read more
-
Research fellowship progressing colorectal cancer research
Hudson Institute’s Cancer Genetics and Functional Genomics Postdoctoral Scientist, Dr Marius Dannappel, has been awarded a highly sought after Research Fellowship from the DFG (German Research Foundation) that will progress his research aimed at developing treatments for colorectal cancer. The two year early career fellowship will enable Dr Dannappel to continue his research into the… Read more
-
Womb to wounds: menstrual fluid could repair damaged skin
Scientists are demonstrating how the womb’s unique ability to rapidly rebuild itself could be harnessed to heal difficult-to-repair chronic wounds affecting 400,000 Australians.… Read more
-
Breathing life into patients with ‘irreversible’ lung disease
Lung fibrosis patients could soon inhale ‘droplets’ of tiny particles derived from stem-like cells found in the human placenta in an effort to repair ‘irreversible’ deadly scarring of the lungs, thanks to world-first research. The regenerative medicine treatment could one day form an alternative for patients with the disease who aren’t eligible for a life-saving… Read more
-
World-first trial of placental cell treatment helping premature babies
A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of… Read more
-
‘Needle in a haystack’ of stem cells found – hope for cerebral palsy
Cells that could be used to repair damage to babies’ brains caused by oxygen starvation during pregnancy or at birth have been identified, bringing hope for the prevention of cerebral palsy. A team of researchers from Hudson Institute of Medical Research and Monash University made the discovery while examining stem cells in umbilical cord blood,… Read more
-
Sparking the skills to take research to industry
PhD student, Anqi Li has been selected to take part in the prestigious SPARK Biomedical Innovation and Entrepreneurship training course in Berlin, Germany this month. The two-week intensive course aims to bridge the gap between industry and academia by helping PhD students to think in creative, innovative and entrepreneurial ways. It is part of the… Read more
-
Melbourne innovation set to revolutionise cell therapy industry
A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and… Read more
-
Outstanding PhD students receive recognition
Graduate research students from The Ritchie Centre took the lion’s share of awards at the recent Perinatal Society of Australia and New Zealand (PSANZ) annual scientific meeting.… Read more
